Health Care
Viewpoints
Filter by:
Advisory on Upcoming Supreme Court Review of the Affordable Care Act
March 23, 2012| Blog
In recognition of the Supreme Court argument that begins on Monday, March 26th, our Health Law Practice and government relations affiliate, ML Strategies, have published an advisory that reviews the key arguments in Florida v. HHS.
OIG Approves Wholly Owned Subsidiary GPO Arrangement
March 21, 2012| Blog
In Advisory Opinion 12-01, the Office of Inspector General for the Department of Health and Human Services (OIG) analyzed a proposal from a nonprofit health system (the “System”) to form a group purchasing organization (the “Proposed GPO”) for the benefit of the System’s affiliates and subsidiaries.
Client Alert - The False Claims Act: The Impact in 2012
March 20, 2012| Blog
Mintz Levin has issued a Client Alert: The False Claims Act: The Impact in 2012 - Part II in a Continuing Series on Health Care Enforcement.
ML Strategies Posts Weekly Health Care Reform Update on March 19, 2012
March 19, 2012| Blog
ML Strategies has posted its weekly Health Care Reform Update. This publication provides timely and concise information on implementation of the Affordable Care Act, and other state and federal administrative and legislative activities related to health care reform.
CMS Clarifies Key ACO Eligibility Requirements
March 19, 2012| Blog
Responding to questions from Medicare Shared Savings Program (MSSP) applicants and their counsel, the Centers for Medicare & Medicaid Services (CMS) issued a memorandum on March 16.
HHS OCR Announces First Settlement of a Self-Reported HIPAA Violation
March 15, 2012| Blog
No one wants to be the first, especially not in this case. The Department of Health and Human Services' Office of Civil Rights (OCR) announced its first settlement with a covered entity stemming from a report submitted pursuant to the Health Information Technology for Economic and Clinical Health Act's (HITECH) Breach Notification Rule (the "Rule").
ML Strategies Posts Weekly Health Care Reform Update on March 12, 2012
March 13, 2012| Blog
ML Strategies has posted its weekly Health Care Reform Update. This publication provides timely and concise information on implementation of the Affordable Care Act, and other state and federal administrative and legislative activities related to health care reform.
New York Court Finds Private Right of Action Under State’s Prompt Pay Law
March 8, 2012| Blog
On February 22, 2012, a New York State Court held for the first time that a provider may bring a claim against a health insurer under the State’s prompt pay law (PPL).
New FDA Research Consent Form Requirements – Effective Today
March 7, 2012| Blog
Starting today, March 7, 2012, clinical research consent forms for certain FDA-regulated clinical trials must contain a specific statement advising participants that clinical trial information will be entered into the ClinicalTrials.gov database.
Summary of Benefits and Coverage: Final Rules Issued, Disclosure Requirements Effective Beginning September 23, 2012
March 5, 2012| Blog
The Affordable Care Act creates a new disclosure requirement for group health plans and issuers: the summary of benefits and coverage (SBC). On February 14, 2012, the Departments of Labor, Treasury, and Health and Human Services published final regulations setting forth the required content, timing, and appearance of the SBC.
ML Strategies Posts Weekly Health Care Reform Update on March 5, 2012
March 5, 2012| Blog
ML Strategies has posted its weekly Health Care Reform Update. This publication provides timely and concise information on implementation of the Affordable Care Act, and other state and federal administrative and legislative activities related to health care reform.
ACGME Announces its Next Accreditation System
March 5, 2012| Blog
On February 22, 2012, the Accreditation Council for Graduate Medical Education (ACGME) announced the roll-out of its “Next Accreditation System” (NAS) for all graduate medical education (residency and fellowship) programs that hold ACGME accreditation.
Government Health Care Enforcement: How 2011 Actions Are Impacting 2012 Priorities
March 1, 2012| Blog
Health care providers and pharmaceutical and medical device manufacturers are operating in an environment of intense scrutiny. As discussed in a Mintz Levin client advisory, in 2011, the federal government directed extraordinary resources and attention to detecting and prosecuting health care fraud and abuse.
CMS Issues Final Payment Error Calculation Methodology for Medicare Advantage RADV Audits
March 1, 2012| Blog
Thirteen months after over 500 comments were submitted in response to a CMS proposal, Medicare Part C (“Medicare Advantage”) plan sponsors and other stakeholders now know the methodology CMS will use in calculating payment errors through extrapolated estimates in audits based on risk adjustment data validation (“RADV”).
Another Attempt to Curb the Sale of Prescription Data Comes Up Empty
February 29, 2012| Blog
Last year, the Supreme Court limited the ability of states to regulate the sale of prescription data. In Sorrell v. IMS Health, the Supreme Court determined that a 2007 Vermont law that effectively banned the sale of prescription data for commercial marketing purposes unless the prescriber consented was an unconstitutional limitation on free speech.
The Best and Worst of HIPAA Compliance
February 24, 2012| Blog
If improving your HIPAA/HITECH compliance policies and procedures is one of your organization's 2012 goals, I encourage you to read an article written by my colleague Ellen Janos entitled The Best and Worst of HIPAA Compliance, which was published in Corporate Compliance Insights.
CMS Proposed Rules for Reporting AMP and Best Price May Have Impact Beyond Medicaid Drug Rebates
February 22, 2012| Blog
On February 2, 2012, CMS issued proposed regulations that further refine and define how pharmaceutical manufacturers must calculate Medicaid drug rebates in the wake of health care reform (the Proposed Rule).
ML Strategies Posts Weekly Health Care Reform Update on February 20, 2012
February 21, 2012| Blog
ML Strategies has posted its weekly Health Care Reform Update. This publication provides timely and concise information on implementation of the Affordable Care Act, and other state and federal administrative and legislative activities related to health care reform.
Clinical Labs Face Additional Fee Cuts in Final Payroll Tax Cut Deal
February 17, 2012| Blog
The clinical laboratory community is dismayed by a last minute, $2.7 billion cut to the Medicare Clinical Laboratory Fee Schedule (CLFS) to help finance the payroll tax and SGR deal.
CMS Publishes Proposed Rule on Return of Medicare and Medicaid Overpayments
February 16, 2012| Blog
Health care providers and suppliers concerned about how the Centers for Medicare & Medicaid Services (CMS) plans to implement the 60-day deadline for returning Medicare and Medicaid overpayments enacted as part of the Affordable Care Act (ACA) now have a proposed rule that provides some insight.
Content Publishers
Theresa C. Carnegie
Member
Karen S. Lovitch
Member / Chair, Health Law Practice
Jordan T. Cohen
Associate
Kate F. Stewart
Associate
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Bankruptcy & Restructuring
- Class Action
- Communications
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Debt Financing
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPR's & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Products Liability & Complex Tort
- Project Development & Finance
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations